ECI830 is an experimental CDK2 inhibitor.
For research use only. We do not sell to patients.
| Name | ECI830 |
|---|---|
| Iupac Chemical Name | 2'-((3-ethoxy-1H-pyrazol-4-yl)amino)-7'-((1R,3R)-3-hydroxycyclohexyl)spiro[cyclopropane-1,5'-pyrrolo[2,3-d]pyrimidin]-6'(7'H)-one |
| Synonyms | ECI830 ; ECI 830 ; ECI-830 |
| Molecular Formula | C19H24N6O3 |
| Molecular Weight | 384.44 |
| Smile | O=C1N([C@@H]2CCC[C@@H](O)C2)C3=NC(NC4=CNN=C4OCC)=NC=C3C15CC5 |
| InChiKey | YIXKYJBZOFQJFD-VXGBXAGGSA-N |
| InChi | InChI=1S/C19H24N6O3/c1-2-28-16-14(10-21-24-16)22-18-20-9-13-15(23-18)25(17(27)19(13)6-7-19)11-4-3-5-12(26)8-11/h9-12,26H,2-8H2,1H3,(H,21,24)(H,20,22,23)/t11-,12-/m1/s1 |
| CAS Number | 3054692-62-2 |
| Related CAS | 3054692-62-2 |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | ≧98.0% |
| Storage | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
| Solubility | Soluble in DMSO (DMSO : ≥ 100 mg/mL) |
| Handling | Refer to MSDS |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| HS Code | 2934200090 |
| Targets | CDK2 inhibitor |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |